Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site

Share Article

The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. The drug's manufacturer issued a nationwide Digitek recall after receiving several reports of injuries or illnesses among patients.

News Image

The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). This site will serve as a news and information resource for patients who may have been prescribed the improperly manufactured Digitek (digoxin) tablets that were recently recalled by their maker, Actavis Totowa.

Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. Digitek and other digoxin drugs work by increasing the amount of calcium in the muscles of the heart, which helps to strengthen a patient’s heartbeat. These drugs also work to slow the signals which cause the heart to beat, decreasing the number of irregular heartbeats, or arrhythmias.

Actavis issued a nationwide Digitek recall on April 25, 2008 after receiving several reports of injuries or illnesses among patients who were taking the drug. According to a press release issued by the company, some Digitek tablets were improperly manufactured at twice their normal thickness. As a result, some patients who were prescribed Digitek may have inadvertently received a double-dose of the drug.

Because the difference between a safe and unsafe amount of Digitek is very small, taking these double-strength pills could cause patients to suffer an overdose due to digoxin toxicity. In some cases, patients who experience a Digitek overdose may suffer a heart attack, stroke or, potentially, death. Other side effects include dizziness and fainting, an irregular heartbeat, low blood pressure, confusion, vomiting, nausea or other symptoms.

In 2006 and 2007, the Food and Drug Administration sent warning letters to Actavis concerning violations of “Good Manufacturing Practices” at the New Jersey plant where Digitek was manufactured. The agency stated that because of these violations, products manufactured at the plant were “adulterated,” meaning that there was no way for the company to make sure that these drugs had the correct “identity, strength, quality and purity” before they were prescribed to patients.

Dozens of individuals who developed serious and potentially deadly injuries after suffering a Digitek overdose have already contacted an attorney about filing a lawsuit against Actavis Totowa and its distributors. These lawsuits have alleged that Digitek tablets were defectively manufactured at twice their normal dose by Actavis. Patients have also alleged that the company failed to heed safety warnings from the FDA about quality control issues at the plant where Digitek was produced, which may have contributed to the Digitek recall.

About Hissey Kientz, LLP
Hissey Kientz, LLP is currently accepting cases involving individuals who may have been injured as a result of a Digitek overdose. Hissey Kientz, LLP also represents those who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by the Ortho Evra patch, Trasylol, the Composix Kugel mesh patch, the Duragesic patch (fentanyl), gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (http://www.hkllp.com) or call toll-free at (866) 275-4454.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Craig Whitney
Visit website